Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference

Rhea-AI Summary

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) will present at the 2021 Jefferies London Healthcare Conference from November 16-19, 2021. The on-demand presentation will be available starting on November 18 at 8 am GMT/3 am EST and will remain accessible until November 19 at 5 pm GMT/12 pm EST. Interested parties can access the webcast via the Aurinia corporate website's Investor section. Aurinia focuses on developing therapies for serious diseases with high unmet medical needs and has introduced the first FDA-approved oral therapy for adults with active lupus nephritis.

VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that the company will deliver a corporate presentation during the 2021 Jefferies London Healthcare Conference -- November 16-19, 2021. The presentation will be available to all conference attendees on demand (link here) beginning on Thursday, November 18 at 8 am GMT/3 am EST through Friday, November 19 at 5 pm GMT/12 pm EST.

Interested parties can also register and access the on-demand webcast through the Investor section of the Aurinia corporate website - www.auriniapharma.com, under "News/Events.”

ABOUT AURINIA

Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company recently introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis (LN). Aurinia’s head office is in Victoria, British Columbia; its U.S. commercial hub is in Rockville, Maryland; and the Company focuses development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005974/en/

Investor and Corporate:

Dana Lynch, IR & Corporate Communications

dlynch@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

When will Aurinia Pharmaceuticals present at the Jefferies London Healthcare Conference?

Aurinia Pharmaceuticals will present during the Jefferies London Healthcare Conference from November 16-19, 2021.

What time does Aurinia's presentation become available for viewing?

Aurinia's presentation will be available on-demand starting on November 18 at 8 am GMT/3 am EST.

How can I access the Aurinia Pharmaceuticals presentation?

You can access the Aurinia Pharmaceuticals presentation through the Investor section of their corporate website.

What is Aurinia's recent FDA approval?

Aurinia recently introduced the first FDA-approved oral therapy for the treatment of active lupus nephritis in adults.

Who can attend the Jefferies London Healthcare Conference presentation by Aurinia?

All conference attendees can access Aurinia's corporate presentation on-demand.